DexCom markets one of the world's most popular constant blood glucose monitors (CGM). These discreet devices adhere to the ...

Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, ...

Today, DexCom is the leading CGM company, with an estimated 40% market share. Importantly, CGM products are relatively nascent. DexCom generates nearly $4 billion in annual sales on a user base of ...

The monitors - which Pharmac is now funding for all type 1 diabetics - mean patients are less likely to suffer early deaths, ...

We recently published a list of 10 Best Healthcare Stocks To Buy According to Hedge Funds. In this article, we are going to ...

MedTech is a promising market driven by rising disease prevalence, innovative healthcare solutions, and significant growth in ...

Ascensia Diabetes Care, a global diabetes care company, announces that it is launching the Eversense® 365 continuous glucose monitoring (CGM) system, the world's only One Year CGM, to people with ...

Eli Lilly has gained markedly over the past decade. But it's not the only S&P 500 health care stock to notch a bullish gain.

Recommended The best diet to prevent Type 2 diabetes Read more Dr David Cavan ... Dr Cavan recommends using a blood glucose monitor such as the Freestyle Libre to see exactly how your body responds to ...

A “fully integrated, wearable” continuous glucose monitor (CGM) is set to transform diabetes care, researchers have said.

The Blood Testing Market is witnessing rapid growth due to advancements in diagnostic technologies and the increasing demand ...